Also in bladder cancer, CpdA was reported to inhibit cell proliferation and induce cell cycle arrest and apoptosis in GR+/AR+ cells, and to reduce tumor growth more strongly than Dex in a xenograft model [37]. Here, AR is linked to urinary bladder carcinoma.